Records containing: Stage IIIA Rectal Cancer AJCC v8
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-15Phase 1b Study to Assess the Safety of Neoadjuvant TAS-102 (Trifluridine/Tipiracil) With Concurrent Radiation in Previously Untreated Resectable Stage II and Stage III Rectal Cancer (FIERCE)
-
CLINICAL_TRIALS study record update · 2026-04-06Prospective Evaluation of Quality of Life and Utilities Following Surgical Treatment of Rectal Cancer
-
CLINICAL_TRIALS study record update · 2026-03-30Organ Preservation for Patients With Locally Advanced Rectal Adenocarcinoma: Evaluating the Efficacy of Short Course Radiation Therapy Followed by FOLFOX or CapeOX
-
CLINICAL_TRIALS study record update · 2026-03-11Circulating Tumor Elements in Patients With Rectal Cancer
-
CLINICAL_TRIALS study record update · 2026-01-28A Phase I Clinical Trial of Regorafenib, Nivolumab, and Ipilimumab in Advanced Chemotherapy Resistant Metastatic MSS Colorectal Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-22Phase Ib/II Trial of SX-682 in Combination With Nivolumab for Refractory RAS Mutated (RAS) Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC) (STOPTRAFFIC-1)
-
CLINICAL_TRIALS study record update · 2025-12-23Open-Label Phase 1b/2 Study of Cetuximab Administered in Combination With LY3214996 (ERK 1/2 Inhibitor) or Cetuximab in Combination With LY3214996 and Abemaciclib in Patients With Metastatic, Anti-EGFR-Refractory Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2025-11-10Pilot Study: Imaging Tumor Extent and Response Before and After Neoadjuvant Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer Using 64Cu-Labeled M5A Antibody to Carcinoembryonic Antigen (CEA)
-
CLINICAL_TRIALS study record update · 2025-11-06Organ Preservation With Active Surveillance After Chemoradiation in Rectal Cancer (OPTION)
-
CLINICAL_TRIALS study record update · 2025-09-25Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
-
CLINICAL_TRIALS study record update · 2025-02-17Longitudinal Assessment of Financial Burden in Patients With Colon or Rectal Cancer Treated With Curative Intent
-
CLINICAL_TRIALS study record update · 2024-05-21PULSE: A Randomized, Phase II Open Label Study of PanitUmumab RechaLlenge Versus Standard Therapy After Progression on Anti-EGFR Therapy in Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2024-01-23COLOMATE: Colorectal Cancer Liquid Biopsy Screening Protocol for Molecularly Assigned Therapy
-
CLINICAL_TRIALS study record update · 2023-08-08A Phase 2 Study of Savolitinib in Subjects With MET Amplified Metastatic Colorectal Cancer